CDK2 and osteosarcoma: In our study, the levels of the CDK2 were significantly decreased in the osteosarcoma U2OS-siRTKN2 cells, which was in complete agreement with the results showing the induction of cell cycle arrest in G1 phase in the U2OS-siRTKN2 U2OS cells.